Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives

Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been associated with excess mortality worldwide. The cardiovascular system is the second most common target of SARS-CoV-2, which leads to severe complications, including acute myocardia...

Full description

Bibliographic Details
Main Authors: Marios Sagris, Panagiotis Theofilis, Alexios S. Antonopoulos, Costas Tsioufis, Evangelos Oikonomou, Charalambos Antoniades, Filippo Crea, Juan Carlos Kaski, Dimitris Tousoulis
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:International Journal of Molecular Sciences
Subjects:
COVID-19
SARS-CoV-2
atherosclerosis
inflammation
anti-inflammatory treatment
Online Access:https://www.mdpi.com/1422-0067/22/12/6607

Internet

https://www.mdpi.com/1422-0067/22/12/6607

Similar Items